Skip to content
Search AI Powered

Latest Stories

GP surgery upgrades to create 8.3 million more annual appointments

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.


The government said this latest step is part of its £26 billion investment into the NHS and a part of its Plan for Change campaign to shift care out of hospital and into the community.

“It will be a long road, but this government is putting in the work to fix our NHS and make it fit for the future,” said health and social care secretary, Wes Streeting, said:

“These are simple fixes for our GP surgeries but for too long they were left to ruin, allowing waiting lists to build and stopping doctors treating more patients.

“It is only because of the necessary decisions we took in the Budget that we are able to invest in GP surgeries, start tackling the 8am scramble and deliver better services for patients.

“The extra investment and reform this government is making, as part of its Plan for Change, will transform our NHS so it can once again be there for you when you need it.”

Lord Darzi’s independent report found that outdated, inefficient buildings create barriers to delivering high-quality patient care and reduce staff productivity.

“Our last survey of members found that 2 in 5 GPs considered their premises unfit for purpose. This not only makes for a poor experience for both patients and practice staff, but it restricts the care and services a practice can provide. Nearly 90 per cent of respondents to our survey said their practice did not have enough consulting rooms, and three-quarters did not have enough space to take on additional GP trainees” said professor Kamila Hawthorne, chair of the Royal College of GPs.

“Today’s announcement is an encouraging interim measure that shows the government is listening and acknowledges that inadequate GP infrastructure needs to be addressed. We now need to see this followed up by further long-term investment.”

The investment will allow GP surgeries to create new consultation and treatment rooms whilst also making better use of existing space.

Projects will be delivered during the 2025 to 2026 financial year, with the first upgrades expected to begin in summer 2025.

In Norwich, Prospect Medical Practice - serving nearly 7,000 patients in some of the city’s most deprived areas - will create new clinical rooms to deliver more patient consultations.

In the Black Country, vacant office spaces in Harden Health Centre will be converted into clinical consulting rooms, allowing more patient access to primary care.

“Bringing GP premises up to a similar condition across England is important to improve patient experience of NHS services, while making primary care a better working environment as we seek to retain and recruit more staff,” said Dr Amanda Doyle, national director for primary care and community services.

“It will also help to create additional space and extend the capacity of current premises as we improve access further and bring care closer to the communities where people live as part of the 10 Year Health Plan.”

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Trump signs executive order to accelerate US-based pharmaceutical manufacturing plants

US president Donald Trump

Pic credit: Getty Images

Trump signs executive order to encourage US drug manufacturing

US president Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country, as part of new regulations to encourage domestic manufacturing.

The order directs the US Food and Drug Administration to streamline reviews and work with domestic manufacturers to provide early support before facilities come online.

Keep ReadingShow less